EAM Investors’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
EAM Investors's VCYT Position: Q2 2026 in Review
EAM Investors opened a new position in Veracyte (VCYT) in Q2 2026: 68,609 shares worth $4.03M. The stake represents 0.36% of the portfolio and ranks #133 among its holdings. This is a return to the name: EAM Investors previously reported a position in VCYT as recently as Q4 2020.
EAM Investors first reported a position in VCYT in Q2 2015 and has held it in 11 quarters since. The position peaked at $4.92M in Q1 2019. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- EAM Investors held 68,609 shares of Veracyte worth $4.03M as of Q2 2026.
- Veracyte was a new EAM Investors position in Q2 2026.
- Veracyte made up 0.36% of EAM Investors's portfolio in Q2 2026, its #133 holding.
- EAM Investors first reported a position in Veracyte in Q2 2015 and has held it in 11 quarters since.
- EAM Investors's Veracyte position peaked at $4.92M in Q1 2019.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.